vildagliptin/metforminklorid genericon 50 mg/850 mg filmom obložene tablete
genericon pharma gesellschaft m.b.h., hafnerstraße 211, graz, austrija - vildagliptin metforminklorid - filmom obložena tableta - urbroj: svaka filmom obložena tableta sadrži 50 mg vildagliptina i 850 mg metforminklorida (što odgovara 663 mg metformina).
acipirin 4 g/0,5 g prašak za otopinu za infuziju
pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb, hrvatska - piperacilinnatrij tazobaktamnatrij - prašak za otopinu za infuziju - 4,0 g + 0,5 g/bočica - urbroj: jedna bočica sadrži 4,0 g piperacilina u obliku piperacilinnatrija i 0,5 g tazobaktama u obliku tazobaktamnatrija
flixonase sprej za nos, suspenzija
glaxosmithkline trading services limited, 12 riverwalk, citywest business campus, dublin 24, irska - flutikazonpropionat - sprej za nos, suspenzija - 500 µg/1 g suspenzije, 50 µg/1 inhalacijska doza - urbroj: 1 g suspenzije sadrži 500 mikrograma flutikazonpropionata 1 inhalacijska doza sadrži 50 mikrograma flutikazonpropionata
gentamicin b. braun 3 mg/ml otopina za infuziju
b. braun adria d.o.o., hondlova 2/9, zagreb - gentamicinsulfat - otopina za infuziju - 3 mg/ml - urbroj: 1 ml otopine za infuziju sadrži 3 mg gentamicina u obliku gentamicin sulfata
maxidex 1 mg/g mast za oko
novartis hrvatska d.o.o., radnička cesta 37b, zagreb, hrvatska - deksametazon - mast za oko - 1 mg/g - urbroj: 1 g masti sadrži 1 mg deksametazona
gefitinib alpha-medical 250 mg filmom obložene tablete
alpha-medical d.o.o., dragutina golika 36, zagreb - gefitinibum - filmom obložena tableta - 250 mg - urbroj: jedna tableta sadrži 250 mg gefitiniba
sandostatin 0,1 mg/ml otopina za injekciju/infuziju
novartis hrvatska d.o.o., radnička cesta 37b, zagreb, hrvatska - oktreotidacetat - otopina za injekciju/infuziju - 0,1 mg/ml - urbroj: jedan ml otopine sadrži 0,1 mg oktreotida u obliku oktreotidacetata
sandostatin 0,5 mg/ml otopina za injekciju/infuziju
novartis hrvatska d.o.o., radnička cesta 37b, zagreb, hrvatska - oktreotidacetat - otopina za injekciju/infuziju - 0,5 mg/ml - urbroj: jedan ml otopine sadrži 0,5 mg oktreotida u obliku oktreotidacetata
ulipristalacetat alvogen 5 mg tablete
alvogen pharma trading europe eood, 86a bulgaria blvd., sofija, bugarska - ulipristalum - tableta - 5 mg - urbroj: jedna tableta sadrži 5 mg ulpristalacetata
enhertu
daiichi sankyo europe gmbh - trastuzumab deruxtecan - neoplazme dojki - antineoplastična sredstva - breast cancerher2-positive breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-positive breast cancer who have received one or more prior anti-her2-based regimens. her2-low breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy (see section 4. non-small cell lung cancer (nsclc)enhertu as monotherapy is indicated for the treatment of adult patients with advanced nsclc whose tumours have an activating her2 (erbb2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy. gastric cancerenhertu as monotherapy is indicated for the treatment of adult patients with advanced her2-positive gastric or gastroesophageal junction (gej) adenocarcinoma who have received a prior trastuzumab-based regimen.